GSDMD and melanoma: When applied to relatively large tumors, the induction of ICD with GSDMD variants proved to be potent in B16F10 melanoma tumor surveillance with around 20–25% long-term survivors regardless of whether NT GSDMD was introduced (Fig. 2) or GSDMD cleavage was induced by the addition of small molecule (Fig. 3).